Does this Ceragon Networks (CRNT) filing show any new insider share purchases or sales?

No explicit new purchases or sales are shown; the entries are classified as holdings with unknown transaction codes. The document functions as an initial statement of beneficial ownership, detailing Ilan Rosen’s existing Ordinary Share and stock option positions rather than recording new trades.

Ceragon director lists share and option holdings

Ceragon Networks Ltd director Ilan Rosen filed an initial statement of beneficial ownership.

Accepted by SEC EDGAR 03/18/2026 - 01:41 PM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Ceragon Networks Ltd director Ilan Rosen filed an initial statement of beneficial ownership. The filing lists his direct holdings of Ordinary Shares and several "Stock Option (Right to Buy)" grants over Ordinary Shares, each with specified exercise prices and expirations between 2027 and 2031. Footnotes state that some shares were issued upon vesting of previously granted RSUs, some were purchased in the open market, and the reported stock options are fully vested and immediately exercisable.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Rosen Ilan

Role Director

Type	Security	Shares	Price	Value
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Ordinary Shares	--	--	--
Holding	Ordinary Shares	--	--	--

Holdings: Stock Option (Right to Buy) — 206,324 contracts (Direct); Ordinary Shares — 61,500 shares (Direct)

Footnotes (3)

F1. These shares were issued upon vesting of previously granted RSU's
F2. The Shares reported herein were purchased in the open market
F3. The Stock Options are Fully vested and immediately exercisable

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Ilan Rosen report owning in Ceragon Networks (CRNT) on this Form 3?

Ilan Rosen reports direct ownership of Ordinary Shares and multiple "Stock Option (Right to Buy)" grants over Ordinary Shares. Each option series has its own exercise price, expiration date, and underlying share amount, defining his potential future equity exposure in Ceragon Networks Ltd.

Are Ilan Rosen’s Ceragon Networks stock options vested and exercisable?

Yes. A footnote explains that the reported Ceragon Networks stock options are fully vested and immediately exercisable. This means Rosen can choose to convert these options into Ordinary Shares at their stated exercise prices any time before the listed expiration dates.

Over what period do Ilan Rosen’s Ceragon Networks stock options expire?

The stock options reported for Ilan Rosen carry expiration dates ranging from 2027 through 2031, depending on the specific grant. Each grant lists a precise expiration date, giving a clear timeframe during which he can exercise those options into Ordinary Shares.

How were some of Ilan Rosen’s Ceragon Networks Ordinary Shares acquired?

Footnotes state that certain shares were issued upon vesting of previously granted RSUs and that some shares were purchased in the open market. This indicates his Ordinary Share holdings come from both equity compensation awards and direct market purchases, as disclosed in the filing.

Why is Ilan Rosen’s Ceragon Networks Form 3 important for investors?

The Form 3 establishes Ilan Rosen’s baseline ownership in Ceragon Networks as a director. It details his direct Ordinary Share holdings and vested stock options, helping investors understand his equity stake and potential alignment with shareholder interests based on disclosed compensation-related awards and prior market purchases.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rosen Ilan

(Last)

(First)

(Middle)

C/O MAGICJACK VOCALTEC LTD.

12 BENNY GOAN STREET, BUILDING 2B

(Street)

NETANYA

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
CERAGON NETWORKS LTD [ CRNT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	56,500⁽¹⁾	D
Ordinary Shares	5,000⁽²⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	07/19/2021⁽³⁾	07/19/2027	Ordinary Shares	16,667	$3.701	D
Stock Option (Right to Buy)	07/20/2022⁽³⁾	07/19/2028	Ordinary Shares	16,667	$2.2167	D
Stock Option (Right to Buy)	07/20/2023⁽³⁾	07/19/2029	Ordinary Shares	16,666	$2.09	D
Stock Option (Right to Buy)	09/08/2023⁽³⁾	09/07/2029	Ordinary Shares	43,334	$1.99	D
Stock Option (Right to Buy)	05/23/2024⁽³⁾	05/23/2030	Ordinary Shares	40,180	$3.08	D
Stock Option (Right to Buy)	05/22/2025⁽³⁾	05/22/2031	Ordinary Shares	22,270	$2.45	D
Stock Option (Right to Buy)	05/23/2025⁽³⁾	05/23/2031	Ordinary Shares	50,540	$2.45	D

Explanation of Responses:

1. These shares were issued upon vesting of previously granted RSU's

2. The Shares reported herein were purchased in the open market

3. The Stock Options are Fully vested and immediately exercisable

Remarks:

This Form 3 is being filed to report the Reporting Person beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.

	Ilan Rosen by: Oppenheimer Israel, as Attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR